Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Do Kim's Stock Ratings
Piper Sandler Analyst
Do Kim is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/04/2025
Overall Average Return
0.54%
Smart Score
Overall Average Return Percentile
41st
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/22/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 90.27% | Do Kim54% | $62 → $63 | Maintains | Overweight | Get Alert |
| 01/18/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 87.25% | Do Kim54% | $60 → $62 | Maintains | Overweight | Get Alert |
| 06/07/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 75.17% | Do Kim54% | → $58 | Assumes | → Overweight | Get Alert |
| 02/21/2023 | TVTX | Buy Now | Travere Therapeutics | $21.15 | 117.49% | Do Kim54% | $42 → $46 | Maintains | Overweight | Get Alert |
| 02/08/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -41.01% | Do Kim54% | → $296 | Maintains | Neutral | Get Alert |
| 02/03/2023 | GILD | Buy Now | Gilead Sciences | $103.68 | 8.02% | Do Kim54% | $111 → $112 | Maintains | Overweight | Get Alert |
| 01/19/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -41.01% | Do Kim54% | $293 → $296 | Maintains | Neutral | Get Alert |
| 01/19/2023 | SDGR | Buy Now | Schrodinger | $24.59 | 253.87% | Do Kim54% | $86 → $87 | Maintains | Overweight | Get Alert |
| 01/19/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 87.25% | Do Kim54% | $60 → $62 | Maintains | Overweight | Get Alert |
| 01/19/2023 | GILD | Buy Now | Gilead Sciences | $103.68 | 7.06% | Do Kim54% | $104 → $111 | Maintains | Overweight | Get Alert |
| 01/19/2023 | CDXS | Buy Now | Codexis | $2.56 | 798.44% | Do Kim54% | $22 → $23 | Maintains | Overweight | Get Alert |
| 01/11/2023 | TVTX | Buy Now | Travere Therapeutics | $21.15 | 98.58% | Do Kim54% | $38 → $42 | Maintains | Overweight | Get Alert |
| 01/06/2023 | TCRR | Buy Now | TCR2 Therapeutics | — | — | Do Kim54% | $8 → $10 | Maintains | Overweight | Get Alert |
| 12/12/2022 | AFMD | Buy Now | Affimed | $0.98 | 512.24% | Do Kim54% | $70 → $60 | Maintains | Overweight | Get Alert |
| 10/28/2022 | GILD | Buy Now | Gilead Sciences | $103.68 | -7.41% | Do Kim54% | $79 → $96 | Upgrade | Neutral → Overweight | Get Alert |
| 10/14/2022 | TVTX | Buy Now | Travere Therapeutics | $21.15 | 79.67% | Do Kim54% | $39 → $38 | Maintains | Overweight | Get Alert |
| 08/17/2022 | RIGL | Buy Now | Rigel Pharmaceuticals | $19.36 | -89.67% | Do Kim54% | $10 → $20 | Maintains | Neutral | Get Alert |
| 08/17/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -42.61% | Do Kim54% | $256 → $288 | Maintains | Neutral | Get Alert |
| 08/16/2022 | REPL | Buy Now | Replimune Group | $10.01 | 329.57% | Do Kim54% | $44 → $43 | Maintains | Overweight | Get Alert |
| 07/26/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -48.98% | Do Kim54% | $242 → $256 | Maintains | Neutral | Get Alert |
| 07/26/2022 | TVTX | Buy Now | Travere Therapeutics | $21.15 | 93.85% | Do Kim54% | $40 → $41 | Maintains | Overweight | Get Alert |
| 07/26/2022 | SDGR | Buy Now | Schrodinger | $24.59 | 249.8% | Do Kim54% | $84 → $86 | Maintains | Overweight | Get Alert |
| 07/26/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 75.17% | Do Kim54% | $55 → $58 | Maintains | Overweight | Get Alert |
| 07/26/2022 | GILD | Buy Now | Gilead Sciences | $103.68 | -31.52% | Do Kim54% | $69 → $71 | Maintains | Neutral | Get Alert |
| 07/26/2022 | EXEL | Buy Now | Exelixis | $39.80 | -19.6% | Do Kim54% | $30 → $32 | Maintains | Overweight | Get Alert |
| 07/26/2022 | ABCL | Buy Now | AbCellera Biologics | $2.41 | 812.83% | Do Kim54% | $21 → $22 | Maintains | Overweight | Get Alert |
| 07/15/2022 | CDXS | Buy Now | Codexis | $2.56 | 759.38% | Do Kim54% | $35 → $22 | Maintains | Overweight | Get Alert |
| 06/23/2022 | SRRK | Buy Now | Scholar Rock Holding | $32.91 | -42.27% | Do Kim54% | $28 → $19 | Maintains | Overweight | Get Alert |
| 05/17/2022 | SRRK | Buy Now | Scholar Rock Holding | $32.91 | -14.92% | Do Kim54% | $56 → $28 | Maintains | Overweight | Get Alert |
| 05/17/2022 | GILD | Buy Now | Gilead Sciences | $103.68 | -33.45% | Do Kim54% | $73 → $69 | Maintains | Neutral | Get Alert |
| 05/11/2022 | ABCL | Buy Now | AbCellera Biologics | $2.41 | 771.33% | Do Kim54% | $28 → $21 | Maintains | Overweight | Get Alert |
| 05/06/2022 | TVTX | Buy Now | Travere Therapeutics | $21.15 | 89.13% | Do Kim54% | $42 → $40 | Maintains | Overweight | Get Alert |
| 05/06/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -51.77% | Do Kim54% | $249 → $242 | Maintains | Neutral | Get Alert |
| 04/29/2022 | GILD | Buy Now | Gilead Sciences | $103.68 | -29.59% | Do Kim54% | $72 → $73 | Maintains | Neutral | Get Alert |
| 04/22/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -50.38% | Do Kim54% | $245 → $249 | Maintains | Neutral | Get Alert |
| 04/04/2022 | GILD | Buy Now | Gilead Sciences | $103.68 | -31.52% | Do Kim54% | $77 → $71 | Maintains | Neutral | Get Alert |
| 03/31/2022 | TVTX | Buy Now | Travere Therapeutics | $21.15 | 98.58% | Do Kim54% | → $42 | Initiates | → Overweight | Get Alert |
| 03/31/2022 | AFMD | Buy Now | Affimed | $0.98 | 614.29% | Do Kim54% | → $70 | Initiates | → Overweight | Get Alert |
| 11/19/2021 | REPL | Buy Now | Replimune Group | $10.01 | 419.48% | Do Kim54% | → $52 | Initiates | → Overweight | Get Alert |
| 11/19/2021 | SDGR | Buy Now | Schrodinger | $24.59 | 253.87% | Do Kim54% | → $87 | Initiates | → Overweight | Get Alert |
| 11/19/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -56.56% | Do Kim54% | $323 → $218 | Downgrade | Overweight → Neutral | Get Alert |
| 11/19/2021 | SRRK | Buy Now | Scholar Rock Holding | $32.91 | 70.16% | Do Kim54% | → $56 | Initiates | → Overweight | Get Alert |
| 11/19/2021 | ABCL | Buy Now | AbCellera Biologics | $2.41 | 1269.24% | Do Kim54% | → $33 | Initiates | → Overweight | Get Alert |
| 05/03/2021 | MORF | Buy Now | Morphic Holding | — | — | Do Kim54% | $111 → $102 | Maintains | Outperform | Get Alert |
| 03/23/2021 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 129.54% | Do Kim54% | $90 → $76 | Maintains | Outperform | Get Alert |
| 03/08/2021 | NUVB | Buy Now | Nuvation Bio | $2.47 | 547.77% | Do Kim54% | → $16 | Initiates | → Outperform | Get Alert |
| 02/02/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -43.4% | Do Kim54% | $302 → $284 | Maintains | Outperform | Get Alert |
| 01/25/2021 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -28.68% | Do Kim54% | → $185 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/25/2021 | CNST | Buy Now | Constellation | — | — | Do Kim54% | $27 → $50 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/05/2021 | ABCL | Buy Now | AbCellera Biologics | $2.41 | 1891.62% | Do Kim54% | → $48 | Initiates | → Outperform | Get Alert |
| 12/18/2020 | XCUR | Buy Now | Exicure | $11.04 | -45.65% | Do Kim54% | → $900 | Initiates | → Outperform | Get Alert |
| 11/06/2020 | RTRX | Buy Now | Retrophin | — | — | Do Kim54% | $31 → $33 | Maintains | Outperform | Get Alert |
| 09/01/2020 | AKCA | Buy Now | Akcea Therapeutics | — | — | Do Kim54% | $26 → $18.15 | Downgrade | Outperform → Market Perform | Get Alert |
| 09/01/2020 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | Do Kim54% | → $32 | Initiates | → Outperform | Get Alert |
| 08/06/2020 | CNST | Buy Now | Constellation | — | — | Do Kim54% | $34 → $28 | Maintains | Market Perform | Get Alert |
| 07/07/2020 | OBSV | Buy Now | ObsEva | — | — | Do Kim54% | $5 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 06/15/2020 | CNST | Buy Now | Constellation | — | — | Do Kim54% | $42 → $34 | Maintains | Market Perform | Get Alert |
| 05/14/2020 | SDGR | Buy Now | Schrodinger | $24.59 | 172.52% | Do Kim54% | $65 → $67 | Maintains | Outperform | Get Alert |
| 05/12/2020 | HALO | Buy Now | Halozyme Therapeutics | $61.19 | -42.8% | Do Kim54% | $27 → $35 | Maintains | Outperform | Get Alert |
| 05/12/2020 | RTRX | Buy Now | Retrophin | — | — | Do Kim54% | $33 → $34 | Maintains | Outperform | Get Alert |
| 05/07/2020 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -34.08% | Do Kim54% | $145 → $171 | Maintains | Outperform | Get Alert |
| 04/30/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -43.6% | Do Kim54% | $279 → $283 | Maintains | Outperform | Get Alert |
| 03/02/2020 | SDGR | Buy Now | Schrodinger | $24.59 | 164.38% | Do Kim54% | → $65 | Initiates | → Outperform | Get Alert |
| 02/27/2020 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 96.32% | Do Kim54% | $70 → $65 | Maintains | Neutral | Get Alert |
| 01/09/2020 | HALO | Buy Now | Halozyme Therapeutics | $61.19 | -60.78% | Do Kim54% | $17 → $24 | Upgrade | Market Perform → Outperform | Get Alert |
| 11/25/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -44.87% | Do Kim54% | $138 → $143 | Maintains | Outperform | Get Alert |
| 11/21/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -46.8% | Do Kim54% | $128 → $138 | Maintains | Outperform | Get Alert |
| 11/13/2019 | MORF | Buy Now | Morphic Holding | — | — | Do Kim54% | $32 → $30 | Maintains | Outperform | Get Alert |
| 11/13/2019 | HALO | Buy Now | Halozyme Therapeutics | $61.19 | -72.22% | Do Kim54% | $16 → $17 | Maintains | Market Perform | Get Alert |
| 11/07/2019 | CNST | Buy Now | Constellation | — | — | Do Kim54% | $17 → $43 | Maintains | Outperform | Get Alert |
| 11/07/2019 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 111.42% | Do Kim54% | $75 → $70 | Maintains | Neutral | Get Alert |
| 11/06/2019 | AKCA | Buy Now | Akcea Therapeutics | — | — | Do Kim54% | $39 → $36 | Maintains | Outperform | Get Alert |
| 10/08/2019 | AKCA | Buy Now | Akcea Therapeutics | — | — | Do Kim54% | $43 → $39 | Maintains | Outperform | Get Alert |
| 08/23/2019 | RTRX | Buy Now | Retrophin | — | — | Do Kim54% | $38 → $33 | Maintains | Outperform | Get Alert |
| 08/13/2019 | MORF | Buy Now | Morphic Holding | — | — | Do Kim54% | $30 → $32 | Maintains | Outperform | Get Alert |
| 07/24/2019 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 186.92% | Do Kim54% | $96 → $95 | Maintains | Outperform | Get Alert |
| 07/22/2019 | MORF | Buy Now | Morphic Holding | — | — | Do Kim54% | → $30 | Initiates | → Outperform | Get Alert |
| 05/02/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -50.65% | Do Kim54% | $126 → $128 | Maintains | Outperform | Get Alert |
| 04/15/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -51.42% | Do Kim54% | $119 → $126 | Maintains | Outperform | Get Alert |
| 04/09/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -54.12% | Do Kim54% | $106 → $119 | Maintains | Outperform | Get Alert |
| 02/28/2019 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 147.66% | Do Kim54% | $70 → $82 | Maintains | Outperform | Get Alert |
| 10/25/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -61.74% | Do Kim54% | $204 → $192 | Maintains | Outperform | Get Alert |
| 10/16/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -52.2% | Do Kim54% | $125 → $124 | Maintains | Outperform | Get Alert |
| 08/28/2018 | AFMD | Buy Now | Affimed | $0.98 | 410.2% | Do Kim54% | $40 → $50 | Maintains | Outperform | Get Alert |
| 08/13/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -51.81% | Do Kim54% | $127 → $125 | Maintains | Outperform | Get Alert |
| 08/13/2018 | CNST | Buy Now | Constellation | — | — | Do Kim54% | → $19 | Initiates | → Outperform | Get Alert |
| 08/09/2018 | AFMD | Buy Now | Affimed | $0.98 | 308.16% | Do Kim54% | $60 → $40 | Maintains | Outperform | Get Alert |
| 08/08/2018 | HALO | Buy Now | Halozyme Therapeutics | $61.19 | -65.68% | Do Kim54% | $19 → $21 | Maintains | Market Perform | Get Alert |
| 08/07/2018 | AKCA | Buy Now | Akcea Therapeutics | — | — | Do Kim54% | $38 → $40 | Maintains | Outperform | Get Alert |
| 07/27/2018 | VBIV | Buy Now | VBI Vaccines | — | — | Do Kim54% | $390 → $360 | Maintains | Outperform | Get Alert |
| 05/31/2018 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 51.01% | Do Kim54% | → $50 | Assumes | → Neutral | Get Alert |
| 05/04/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -48.34% | Do Kim54% | $160 → $134 | Maintains | Outperform | Get Alert |
| 05/04/2018 | AKCA | Buy Now | Akcea Therapeutics | — | — | Do Kim54% | $42 → $38 | Maintains | Outperform | Get Alert |
| 05/02/2018 | RIGL | Buy Now | Rigel Pharmaceuticals | $19.36 | -48.35% | Do Kim54% | $80 → $100 | Maintains | Outperform | Get Alert |
| 04/25/2018 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 123.5% | Do Kim54% | $75 → $74 | Maintains | Outperform | Get Alert |
| 04/23/2018 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 126.52% | Do Kim54% | $70 → $75 | Maintains | Outperform | Get Alert |
| 04/18/2018 | RIGL | Buy Now | Rigel Pharmaceuticals | $19.36 | -58.68% | Do Kim54% | $60 → $80 | Maintains | Outperform | Get Alert |
| 04/04/2018 | RTRX | Buy Now | Retrophin | — | — | Do Kim54% | $44 → $43 | Maintains | Outperform | Get Alert |
| 03/06/2018 | FATE | Buy Now | Fate Therapeutics | $1.33 | 1403.76% | Do Kim54% | $7 → $20 | Maintains | Outperform | Get Alert |
| 02/28/2018 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 96.32% | Do Kim54% | $64 → $65 | Maintains | Outperform | Get Alert |
| 02/27/2018 | AKCA | Buy Now | Akcea Therapeutics | — | — | Do Kim54% | $25 → $30 | Maintains | Outperform | Get Alert |
| 02/22/2018 | HALO | Buy Now | Halozyme Therapeutics | $61.19 | -68.95% | Do Kim54% | $18 → $19 | Maintains | Market Perform | Get Alert |
| 02/09/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -38.32% | Do Kim54% | $165 → $160 | Maintains | Outperform | Get Alert |
| 02/01/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -61.94% | Do Kim54% | $184 → $191 | Maintains | Outperform | Get Alert |
| 11/15/2017 | VBIV | Buy Now | VBI Vaccines | — | — | Do Kim54% | → $330 | Initiates | → Outperform | Get Alert |
| 11/08/2017 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 96.32% | Do Kim54% | $64 → $65 | Maintains | Outperform | Get Alert |
| 11/08/2017 | HALO | Buy Now | Halozyme Therapeutics | $61.19 | -70.58% | Do Kim54% | $15 → $18 | Maintains | Market Perform | Get Alert |
| 09/22/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -48.34% | Do Kim54% | $99 → $134 | Maintains | Outperform | Get Alert |
| 09/15/2017 | HALO | Buy Now | Halozyme Therapeutics | $61.19 | -75.49% | Do Kim54% | $14 → $15 | Maintains | Market Perform | Get Alert |
| 09/08/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -61.83% | Do Kim54% | $105 → $99 | Maintains | Outperform | Get Alert |
| 08/14/2017 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 108.4% | Do Kim54% | $67 → $69 | Maintains | Outperform | Get Alert |
| 08/08/2017 | AKCA | Buy Now | Akcea Therapeutics | — | — | Do Kim54% | → $25 | Initiates | → Outperform | Get Alert |
| 07/26/2017 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | 102.36% | Do Kim54% | $59.56 → $67 | Maintains | Outperform | Get Alert |
| 04/17/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $259.39 | -71.86% | Do Kim54% | → $73 | Initiates | → Outperform | Get Alert |
| 04/17/2017 | HALO | Buy Now | Halozyme Therapeutics | $61.19 | -77.12% | Do Kim54% | → $14 | Initiates | → Market Perform | Get Alert |
| 03/29/2017 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | — | Do Kim54% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 10/06/2016 | IONS | Buy Now | Ionis Pharmaceuticals | $33.11 | — | Do Kim54% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 04/12/2016 | AFMD | Buy Now | Affimed | $0.98 | 614.29% | Do Kim54% | → $70 | Initiates | → Outperform | Get Alert |
| 04/12/2016 | RTRX | Buy Now | Retrophin | — | — | Do Kim54% | → $25 | Initiates | → Outperform | Get Alert |
| 04/07/2016 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | — | Do Kim54% | — | Initiates | → Market Perform | Get Alert |
| 03/03/2015 | HALO | Buy Now | Halozyme Therapeutics | $61.19 | -57.51% | Do Kim54% | $24 → $26 | Maintains | Outperform | Get Alert |
| 10/07/2014 | AFMD | Buy Now | Affimed | $0.98 | 1226.53% | Do Kim54% | → $130 | Initiates | → Outperform | Get Alert |
| 02/01/2013 | HALO | Buy Now | Halozyme Therapeutics | $61.19 | -85.29% | Do Kim54% | $12 → $9 | Maintains | Outperform | Get Alert |
| 01/14/2013 | HALO | Buy Now | Halozyme Therapeutics | $61.19 | -80.39% | Do Kim54% | → $12 | Upgrade | Market Perform → Outperform | Get Alert |
